Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Postpartum Hemorrhage in Hemophilia a and B Carriers after Enhanced Prophylactic Clotting Factor Suppletion: The Pregnancy and Inherited Bleeding Disorders Study (PRIDES)

Anne de Vaan, Marieke JHA Kruip, Jeroen Eikenboom, Marieke C Punt, Michiel Coppens, Laurens Nieuwenhuizen, Saskia EM Schols, Anja BU Mäkelburg, Floor CJI Moenen, Hans JJ Duvekot, Marjolein Peters, Annemieke JM Middeldorp, Kitty WM Bloemenkamp, Roger EG Schutgens, Titia AT Lely, Karin PM van Galen

Blood (2024) 144 (Supplement 1): 129.

https://doi.org/10.1182/blood-2024-207022

Published: 2024

Journal Articles

The Influence of Postpartum Hemorrhage on Patient Reported Outcomes Among Women with Von Willebrand Disease: The Pregnancy and Inherited Bleeding Disorders Study (PRIDES)

Anne de Vaan, Jeroen Eikenboom, Marieke JHA Kruip, Elke A Doeff, Marieke C Punt, Michiel Coppens, Laurens Nieuwenhuizen, Saskia EM Schols, Anja BU Mäkelburg, Floor CJI Moenen, Hans JJ Duvekot, Marjolein Peters, Annemieke JM Middeldorp, Kitty WM Bloemenkamp, Roger EG Schutgens, Karin PM van Galen

Blood (2024) 144 (Supplement 1): 2601.

https://doi.org/10.1182/blood-2024-207071

Published: 2024

Journal Articles

Postpartum Hemorrhage in Women with Von Willebrand Disease after Enhanced Prophylactic Clotting Factor Suppletion: The Pregnancy and Inherited Bleeding Disorders Study (PRIDES)

Anne De Vaan, Jeroen Eikenboom, Marieke JHA Kruip, Marieke C Punt, Michiel Coppens, Laurens Nieuwenhuizen, Saskia EM Schols, Anja BU Mäkelburg, Floor CJI Moenen, Hans JJ Duvekot, Marjolein Peters, Annemieke JM Middeldorp, Kitty WM Bloemenkamp, Roger EG Schutgens, Titia AT Lely, Karin PM Van Galen

Blood (2024) 144 (Supplement 1): 2595.

https://doi.org/10.1182/blood-2024-193986

Published: 2024

Journal Articles

Targeting Clotting Factor VIII Plasma Values in the Perioperative Setting in Hemophilia a: “Tackling a Moving Target” (“OPTI-CLOT” Studies)

Janske Lock, MD PhDstudent, Hendrika C.A.M. Hazendonk, MD PhDstudent, Ron A.A. Mathôt, Prof. Dr., Karina Meijer, MD PhD, Marjolein Peters, MD PhD, Paul Brons, Felix J.M. Van der Meer, MD PhD, Hannan Bouzariouh, MD, Mariette H.E. Driessens, PhD, Karin Fijnvandraat, MD PhD, Frank W.G. Leebeek, MD PhD, Marjon H. Cnossen, MD PhD

Blood (2014) 124 (21): 5031.

https://doi.org/10.1182/blood.V124.21.5031.5031

Published: 2014

Journal Articles

Towards Successful Implementation of Pharmacokinetic-Guided Prophylactic Dosing of Clotting Factor Concentrate in Hemophilia; The Do’s and Don’ts after Discrete Choice Experiment Analysis

Janske Lock, MD PhDstudent, Esther W. de Bekker-Grob, PhD, Gamze Urhan, MD, Saskia Middeldorp, MD PhD, Marjolein Peters, MD PhD, Karina Meijer, MD PhD, Rienk Y.J. Tamminga, MD PhD, Britta Laros-van Gorkum, MD PhD, Paul Brons, Felix J.M. Van der Meer, MD PhD, Mariette H.E. Driessens, PhD, Peter W. Collins, MD, Karin Fijnvandraat, MD PhD, Frank W.G. Leebeek, MD PhD, Marjon H. Cnossen, MD PhD

Blood (2014) 124 (21): 5038.

https://doi.org/10.1182/blood.V124.21.5038.5038

Published: 2014

Journal Articles

Alloantibody Formation In Sickle Cell Disease

Joep Sins, MD, MSc, Saurabh Zalpuri, MD, PhD, Marjon Cnossen, MD, PhD, Anita W. Rijneveld, MD, PhD, Jean-Louis Kerkhoffs, MD, PhD, Alfred van Meurs, MD, Yolanda de Rijke, PhD, Marjolein Peters, MD, PhD, Bart J. Biemond, MD, PhD, Anske van der Bom, MD, PhD, Karin Fijnvandraat, MD, PhD

Blood (2013) 122 (21): 2395.

https://doi.org/10.1182/blood.V122.21.2395.2395

Published: 2013

Journal Articles

Factor VIII gene ( F8 ) mutation and risk of inhibitor development in nonsevere hemophilia A

Corien L. Eckhardt, Alice S. van Velzen, Marjolein Peters, Jan Astermark, Paul P. Brons, Giancarlo Castaman, Marjon H. Cnossen, Natasja Dors, Carmen Escuriola-Ettingshausen, Karly Hamulyak, Daniel P. Hart, Charles R. M. Hay, Saturnino Haya, Waander L. van Heerde, Cedric Hermans, Margareta Holmström, Victor Jimenez-Yuste, Russell D. Keenan, Robert Klamroth, Britta A. P. Laros-van Gorkom, Frank W. G. Leebeek, Ri Liesner, Anne Mäkipernaa, Christoph Male, Evelien Mauser-Bunschoten, Maria G. Mazzucconi, Simon McRae, Karina Meijer, Michael Mitchell, Massimo Morfini, Marten Nijziel, Johannes Oldenburg, Kathelijne Peerlinck, Pia Petrini, Helena Platokouki, Sylvia E. Reitter-Pfoertner, Elena Santagostino, Piercarla Schinco, Frans J. Smiers, Berthold Siegmund, Annarita Tagliaferri, Thynn T. Yee, Pieter Willem Kamphuisen, Johanna G. van der Bom, Karin Fijnvandraat

Blood (2013) 122 (11): 1954–1962.

https://doi.org/10.1182/blood-2013-02-483263

Published: 2013

Includes: Supplemental data

Journal Articles

Pregnancy Complications In Sickle Cell Disease Are More Prevalent In Women with Vaso-Occlusion Related Organ Damage Than Hemolysis Related Organ Damage

Charlotte F.J. van Tuijn, MSc, Roosmarijn G. van der Stap, MD, Joris A.M. van der Post, MD, PhD, Marjolein Peters, MD, PhD, Bart J. Biemond, MD, PhD

Blood (2010) 116 (21): 2661.

https://doi.org/10.1182/blood.V116.21.2661.2661

Published: 2010

Journal Articles

Heart Function Disorders In Sickle Cell Disease

Charlotte Heinen, Karin Fijnvandraat, MD, PhD, Marjolein Peters, MD, PhD, Henriette Heijboer, MD, PhD, Nico Blom, MD, PhD, Irene Kuipers, MD, PhD

Blood (2010) 116 (21): 4815.

https://doi.org/10.1182/blood.V116.21.4815.4815

Published: 2010

Journal Articles

Mortality and Causes of Death in Children with Sickle Cell Disease in the Netherlands.

Evelyn M. van der Plas, Xandra W. van den Tweel, Harriët Heijboer, Ronald B. Geskus, B. J. Biemond, Marjolein Peters, MD, PhD, Karin Fijnvandraat

Blood (2009) 114 (22): 1519.

https://doi.org/10.1182/blood.V114.22.1519.1519

Published: 2009

Journal Articles

Behavioral and Emotional Problems in Children with Sickle Cell Disease

Channa Hijmans, Martha Grootenhuis, Jaap Oosterlaan, Marit van Oirschot, Carla Hendriks, Harriët Heijboer, Marjolein Peters, Bob Last, Karin Fijnvandraat

Blood (2008) 112 (11): 4817.

https://doi.org/10.1182/blood.V112.11.4817.4817

Published: 2008

Journal Articles

Role of Glycoprotein Ibα Mobility in Platelet Function.

Dianne E van der Wal, Sandra Verhoef, Roger EG Schutgens, Marjolein Peters, MD, PhD, Jan-Willem Akkerman, PhD

Blood (2008) 112 (11): 1850.

https://doi.org/10.1182/blood.V112.11.1850.1850

Published: 2008

Journal Articles

Social participation of patients with hemophilia in the Netherlands

Iris Plug, Marjolein Peters, Eveline P. Mauser-Bunschoten, Arja de Goede-Bolder, Lily Heijnen, Cees Smit, José Willemse, Frits R. Rosendaal, Johanna G. van der Bom

Blood (2008) 111 (4): 1811–1815.

https://doi.org/10.1182/blood-2007-07-102202

Published: 2008

Journal Articles

Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura

Willemijn B. Breunis, Edwin van Mirre, Marrie Bruin, Judy Geissler, Martin de Boer, Marjolein Peters, Dirk Roos, Masja de Haas, Harry R. Koene, Taco W. Kuijpers

Blood (2008) 111 (3): 1029–1038.

https://doi.org/10.1182/blood-2007-03-079913

Published: 2008

Includes: Supplemental data

Journal Articles

Development and Validation of a Pediatric Severity Index for Sickle Cell Patients.

Xandra W. van den Tweel, MD, Johanna H. van der Lee, MD, Harriët Heijboer, MD PhD, Marjolein Peters, MD PhD, Karin Fijnvandraat, MD PhD

Blood (2007) 110 (11): 3391.

https://doi.org/10.1182/blood.V110.11.3391.3391

Published: 2007

Journal Articles

Thirty years of hemophilia treatment in the Netherlands, 1972-2001

Iris Plug, Johanna G. van der Bom, Marjolein Peters, Evelien P. Mauser-Bunschoten, Arja de Goede-Bolder, Lily Heijnen, Cees Smit, Jeannette E. F. Zwart-van Rijkom, José Willemse, Frits R. Rosendaal

Blood (2004) 104 (12): 3494–3500.

https://doi.org/10.1182/blood-2004-05-2008

Published: 2004

Journal Articles

Two classes of germline genes both derived from the V H 1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII

Edward N. van den Brink, Wendy S. Bril, Ellen A. M. Turenhout, Marleen Zuurveld, Niels Bovenschen, Marjolein Peters, Thynn Thynn Yee, Koen Mertens, Deborah A. Lewis, Thomas L. Ortel, Pete Lollar, Dorothea Scandella, Jan Voorberg

Blood (2002) 99 (8): 2828–2834.

https://doi.org/10.1182/blood.V99.8.2828

Published: 2002

Journal Articles

Multiple VH genes are used to assemble human antibodies directed toward the A3-C1 domains of factor VIII

Edward N. van den Brink, Ellen A. M. Turenhout, Niels Bovenschen, Bram G. A. D. H. Heijnen, Koen Mertens, Marjolein Peters, Jan Voorberg

Blood (2001) 97 (4): 966–972.

https://doi.org/10.1182/blood.V97.4.966

Published: 2001

Journal Articles

Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain: Presented in part at the 41st Annual Meeting of the American Society of Hematology, December 3-7, 1999, New Orleans, LA.

Edward N. van den Brink, Ellen A. M. Turenhout, Christine M. C. Bank, Karin Fijnvandraat, Marjolein Peters, Jan Voorberg

Blood (2000) 96 (2): 540–545.

https://doi.org/10.1182/blood.V96.2.540

Published: 2000

Journal Articles

Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes

Edward N. van den Brink, Ellen A. M. Turenhout, Julian Davies, Niels Bovenschen, Karin Fijnvandraat, Willem H. Ouwehand, Marjolein Peters, Jan Voorberg

Blood (2000) 95 (2): 558–563.

https://doi.org/10.1182/blood.V95.2.558

Published: 2000

NARROW

Postpartum Hemorrhage in Hemophilia a and B Carriers after Enhanced Prophylactic Clotting Factor Suppletion: The Pregnancy and Inherited Bleeding Disorders Study (PRIDES)

The Influence of Postpartum Hemorrhage on Patient Reported Outcomes Among Women with Von Willebrand Disease: The Pregnancy and Inherited Bleeding Disorders Study (PRIDES)

Postpartum Hemorrhage in Women with Von Willebrand Disease after Enhanced Prophylactic Clotting Factor Suppletion: The Pregnancy and Inherited Bleeding Disorders Study (PRIDES)

Targeting Clotting Factor VIII Plasma Values in the Perioperative Setting in Hemophilia a: “Tackling a Moving Target” (“OPTI-CLOT” Studies)

Towards Successful Implementation of Pharmacokinetic-Guided Prophylactic Dosing of Clotting Factor Concentrate in Hemophilia; The Do’s and Don’ts after Discrete Choice Experiment Analysis

Alloantibody Formation In Sickle Cell Disease

Factor VIII gene ( F8 ) mutation and risk of inhibitor development in nonsevere hemophilia A

Pregnancy Complications In Sickle Cell Disease Are More Prevalent In Women with Vaso-Occlusion Related Organ Damage Than Hemolysis Related Organ Damage

Heart Function Disorders In Sickle Cell Disease

Mortality and Causes of Death in Children with Sickle Cell Disease in the Netherlands.

Behavioral and Emotional Problems in Children with Sickle Cell Disease

Role of Glycoprotein Ibα Mobility in Platelet Function.

Social participation of patients with hemophilia in the Netherlands

Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura

Development and Validation of a Pediatric Severity Index for Sickle Cell Patients.

Thirty years of hemophilia treatment in the Netherlands, 1972-2001

Two classes of germline genes both derived from the V H 1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII

Multiple VH genes are used to assemble human antibodies directed toward the A3-C1 domains of factor VIII

Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain: Presented in part at the 41st Annual Meeting of the American Society of Hematology, December 3-7, 1999, New Orleans, LA.

Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only